EUR 73,27
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: New. New hardcover with no dust jacket. An unread/unopened copy. May have very minor rubbing and scuffing from shelf.; 100% Satisfaction Guaranteed! Ships same or next business day!
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 92,64
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: preigu, Osnabrück, Alemania
EUR 51,10
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. First line therapy in Multiple Myeloma | Overview of recent therapy in treatment of new Multiple Myeloma patients | Ahmed Rabea | Taschenbuch | 140 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783846557945 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por Lap Lambert Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: Revaluation Books, Exeter, Reino Unido
EUR 116,35
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 140 pages. 8.66x5.91x0.32 inches. In Stock.
Idioma: Inglés
Publicado por Lap Lambert Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: Revaluation Books, Exeter, Reino Unido
EUR 123,16
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 140 pages. 8.66x5.91x0.32 inches. In Stock.
EUR 138,59
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 135,06
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: Majestic Books, Hounslow, Reino Unido
EUR 93,77
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 95,35
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3846557943 ISBN 13: 9783846557945
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 59,71
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the past, survival in Multiple Myeloma was in the range of 1 to 3 years. With the introduction of the novel drugs as the immunomodulators (IMiDs) and Proteosome inhibitors, survival has markedly increased and quality of life has improved. In this book, I have given an overview of the novel drugs and their use as first line therapy in multiple myeloma aiming for better prognosis, survival and quality of life.
Librería: preigu, Osnabrück, Alemania
EUR 104,45
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Multiple Myeloma | An Overview | Ajay Gupta | Buch | 286 S. | Englisch | 2012 | IntechOpen | EAN 9789533077680 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu Print on Demand.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 130,55
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Multiple myeloma is a malignant disorder characterized by the proliferation of plasma cells. Much insight has been gained into the molecular pathways that lead to myeloma and indeed much more remains to be done. The understanding of these pathways is closely linked to their therapeutic implications and is stressed upon in the initial chapters. Recently, the introduction of newer agents such as bortezomib, lenalidomide, thalidomide, liposomal doxorubicin, etc. has led to a flurry of trials aimed at testing various combinations in order to improve survival. Higher response rates observed with these agents have led to their integration into induction therapies. The role of various new therapies vis a vis transplantation has also been examined. Recent advances in the management of plasmacytomas , renal dysfunction, dentistry as well as mobilization of stem cells in the context of myeloma have also found exclusive mention. Since brevity is the soul of wit our attempt has been to present before the reader a comprehensive yet brief text on this important subject.